GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a potential treatment for obese people with the respiratory condition, who ...

Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...

Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.

GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

The "try and fail" language is flawed when weight loss is used as the primary measure of success with lifestyle interventions ...

Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular disease.

New study reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Here's what they found.

Curious about the viral “Japanese Mounjaro” drink? Learn what it is, what it’s made of, and whether it can actually support weight loss like the prescription medication Mounjaro.